- Stocks
- Pharma & Healthcare
- KK Shah Hospita
KK Shah Hospita share price
NSE: KKSHLPharma & HealthcareMedical Care Facilities
KK Shah Hospita at a glance
With a market capitalisation of ₹30 Cr, it ranks 3370th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
Its return on equity was −2.4% in FY25. In Q2 FY24, the quarter ended 30 Sep 2023, revenue was ₹3 Cr and net profit ₹0 Cr, on a standalone basis. Promoters held 71.36% of the company as of 31 Mar 2026.
Key numbers
- Market cap
- ₹30 CrRank 3370 on NSE
- Price to book
- 2.36×FY25
- ROE
- −2.4%FY25
- ROCE
- −2.4%FY25
- Debt to equity
- 0FY25
- Net profit margin
- −3.6%FY25
- Book value / share
- ₹19.70FY25
- Dividend payout
- −104.0%FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
KK Shah Hospita quarterly results
| Quarter | Q1 FY24 | Q2 FY24 |
|---|---|---|
| Revenue | ₹2 Cr | ₹3 Cr |
| Revenue YoY | — | — |
| Net profit | ₹0 Cr | ₹0 Cr |
| Net profit YoY | — | — |
| Net margin | 6.2% | 7.1% |
| EPS | ₹0.20 | ₹0.50 |
KK Shah Hospita financials
| Item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | ₹2 Cr | ₹7 Cr | ₹9 Cr |
| Operating profit | ₹0 Cr | ₹1 Cr | −₹0 Cr |
| Net profit | ₹0 Cr | ₹1 Cr | −₹0 Cr |
| EPS (₹) | ₹0.45 | ₹1.07 | −₹0.48 |
| Cash from operations | ₹1 Cr | −₹1 Cr | ₹2 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹5 Cr | ₹14 Cr | ₹13 Cr |
KK Shah Hospita shareholding pattern
| Holder | 2 Nov 2023 | 31 Mar 2024 | 30 Sep 2024 | 31 Mar 2025 | 30 Sep 2025 | 31 Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 71.36% | 71.36% | 71.36% | 71.36% | 71.36% | 71.36% |
| Non-institutions | 28.64% | 28.64% | 28.64% | 28.64% | 28.64% | 28.64% |
KK Shah Hospita vs peers
The listed Pharma & Healthcare companies nearest to KK Shah Hospita by market capitalisation.
Ask anything about KK Shah Hospita
Pivot answers on the live chart with evidence you can check, and tests strategies against KKSHL's own history. Try: “Why has KKSHL moved over the last three months?” · “Backtest a 50-day moving-average crossover on KKSHL over five years” · “Compare KKSHL with DECCAN on margins and valuation”
Frequently asked questions about KK Shah Hospita
What is the market cap of KK Shah Hospita?
KK Shah Hospita's market capitalisation is ₹30 Cr (₹30 Cr) at the 22 Oct 2026 close, ranking 3370th among the NSE companies Pivot tracks.
What is the ROE and ROCE of KK Shah Hospita?
Return on equity was −2.4% in FY25 and return on capital employed was −2.4% in FY25 (standalone figures).
Is KK Shah Hospita a debt-free company?
KK Shah Hospita is close to debt-free: its debt-to-equity ratio was 0 in FY25.
What were KK Shah Hospita's latest quarterly results?
For Q2 FY24 (quarter ended 30 Sep 2023), KK Shah Hospita reported revenue of ₹3 Cr and net profit of ₹0 Cr.
What is the shareholding pattern of KK Shah Hospita?
As of 31 Mar 2026: promoters 71.36%, non-institutions 28.64%.
Who are KK Shah Hospita's competitors?
The listed Pharma & Healthcare companies closest to KK Shah Hospita by market cap are Deccan Health C, Medi-Caps, Panjon, Soni Medicare, Chennai Meenaks and Tejnaksh.
Is KK Shah Hospita a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out KK Shah Hospita's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KKSHL against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with K · all NSE stocks · this page as text